Compare Funko Inc (FNKO) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Funko Inc vs HCA Health Inc — how do they compare? Funko Inc trades at $5.74 (market cap $315.21M), while HCA Health Inc trades at $386.2 (market cap $84.04B). The key difference: HCA Health Inc is far larger — about 266.6× Funko Inc's market cap, and HCA Health Inc pays a 0.82% dividend while Funko Inc pays none. Which is the better fit depends on your goals.
| FNKO | HCA | |
|---|---|---|
Market Cap | $315.21M | $84.04B |
Sector | Consumer Staples | Health |
52-Week High | $5.88 | $545.13 |
52-Week Low | $2.46 | $334.32 |
Enterprise Value | $560.25M | $132.95B |
Dividend Yield | — | 0.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FNKO trades at $5.785, up 4.23% today, with a bullish technical signal from moving averages. The stock shows improving revenue trends, with Q1 2026 sales reaching $200.9M, beating expectations, though net income remains negative. Analyst consensus is split between Buy and Hold, with no Sell ratings. Recent news highlights new product launches and strong collectibles demand, supporting a positive sentiment shift.
Outlook: FNKO presents a speculative opportunity with recent earnings beats and revenue growth, but risks include persistent net losses and high debt. Investors should weigh the bullish technicals and product momentum against fundamental weaknesses in profitability and cash flow volatility.
HCA Healthcare (HCA) trades at $389.90, up 7.23% over the past 24 hours, with strong recent earnings beats but a bearish technical signal. The stock shows solid fundamentals with 2025 revenue of $75.60B and net income of $6.78B, supported by a P/E of 13.05 and net margin of 8.89%. However, recent news highlights guidance cuts due to payer mix shifts and rising uninsured patients, creating near-term headwinds.
The outlook is mixed: analyst consensus remains bullish with a $469.40 price target, but technical indicators and recent guidance reductions suggest caution. Key risks include margin compression and debt levels, while long-term growth drivers like capacity expansion and gene therapy research offer potential upside. Investors should weigh strong valuation metrics against operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Funko Inc
Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
